RecruitingPhase 3NCT06624592
Sevoflurane/Dexmedetomidine vs. Isoflurane for Pediatric Emergence Delirium
Sevoflurane/Dexmedetomidine vs. Isoflurane and Their Effects on Pediatric Emergence Delirium
Sponsor
Mayo Clinic
Enrollment
400 participants
Start Date
Dec 20, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
The purpose of this study is to measure the incidences of pediatric emergence delirium between the group receiving Isoflurane and the group receiving Sevoflurane plus intravenous push dexmedetomidine.
Eligibility
Min Age: 2 YearsMax Age: 7 Years
Inclusion Criteria4
- Pediatric patients aged 2-7 years.
- Surgeries include ENT cases (i.e., tonsillectomy/adenoidectomy), ophthalmology cases (i.e., strabismus), and urology cases.
- Can be outpatient or General Care inpatient procedures.
- All cases must include an IV and an endotracheal tube (ETT).
Exclusion Criteria4
- Severe developmental/cognitive delay (unable to make eye contact, nonverbal, or inability to interact with providers for PAED scale assessment requirements)
- TIVA cases.
- No PIV in place during the case, planned PICU admission postoperatively.
- Previous history of severe emergence delirium documented by a provider (via interventions or explicitly stated).
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGSevoflurane
Subjects will receive standard of care anesthesia Sevoflurane, with intravenous push Dexmedetomidine
DRUGIsoflurane
Subjects will receive standard of care anesthesia Isoflurane
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06624592